source
- Apnimed announces IPO plans while FDA reviews its sleep-apnea therapyApnimed, a Cambridge, Massachusetts biotech, disclosed that it will pursue an initial public offering on Nasdaq. The move comes as the company’s lead sleep‑apnea candidate is under review by the U…
- Nominee for HHS emergency response role has a history of questioning vaccinesSean Kaufman has been selected by the administration to lead the Office of Assistant Secretary for Preparedness and Response, overseeing the nation’s reaction to public health emergencies and disas…